DCB vs DES in Patients With De Novo Coronary Artery Disease: A Meta-Analysis of Randomized Trials
A meta-analysis of randomized trials demonstrated that among patients with de novo coronary artery disease undergoing PCI, the mid-term risk of MACE, defined as cardiac death, myocardial infarction, and target lesion revascularization, was comparable between treatment with drug-coated balloons and drug-eluting stents, Dr. Daniel O’Callaghan and colleagues, Mater Private Network, Ireland, reported in the September 1 issue of Catheterization & Cardiovascular Interventions.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
